NVCT Earnings

Quarterly EPS
$-0.24
Q3 2024
$-0.35
Q4 2024
$-0.27
Q1 2025
$-0.30
Q2 2025
$-0.44
Q3 2025
$-0.31
Q4 2025
$-0.26
Q1 2026
$-0.30
Q2 2026
Latest RevenueN/A
Latest Net Income-7020000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.300-7020000+0.0%
Q1 2026-$0.260-6050000+3.7%
Q4 2025-$0.310-7314000+11.4%
Q3 2025-$0.440-7462000-83.3%
Q2 2025-$0.300-6334000-15.4%
Q1 2025-$0.270-5332000-8.0%
Q4 2024-$0.350-6248000+14.6%
Q3 2024-$0.240-4153000+35.1%
Q2 2024-$0.260-4428000
Q1 2024-$0.250-4171000
Q4 2023-$0.410-6622000
Q3 2023-$0.370-5881000
Nuvectis Pharma (NVCT) — Earnings